Otsuka
Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Abilify | Aripiprazole | 2002-11-15 | 2023-2034 | |
| Breathtek ubt for h-pylori | Urea c | 1996-09-17 | — | |
| Busulfex | Busulfan | 1999-02-04 | ||
| Dacogen | Decitabine | 2006-05-02 | 2028-2030 | |
| Deltyba | Delamanid | 2014-04-27 | ||
| Inqovi | Cedazuridine, Decitabine | 2020-07-07 | 2028-2030 | |
| Jinarc | Tolvaptan | 2015-05-27 | 2026-2030 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use